Funding Alert: Parakeet Health Raises $10M Series A to Run Patient Scheduling with Agents

🌏 中文版

Deal Terms

What the Company Does

Parakeet Health automates patient access for healthcare organizations — it's a conversational agent platform that absorbs the scattered phone calls, faxes, texts, and web scheduling requests that currently leak between a patient's demand for care and an actual booked appointment.

The product runs inbound calls, proactive outreach, fax processing, and web scheduling through a single workflow: a referral that arrives by fax can move straight into outreach, scheduling, and follow-up without leaving the platform, with every action landing on one performance dashboard — replacing the pile of disconnected point tools most clinics run today. It integrates with existing EHR and practice-management systems and adapts to each organization's providers, locations, insurance rules, and scheduling logic. In a head-to-head pilot, Parakeet's inbound phone agent hit 2.3x the resolution rate of an established AI voice vendor.

The company now works with six of the ten largest dermatology groups in the US, supporting more than 2,800 providers across 1,100+ locations, and recently struck a national partnership with Qualderm Partners, which spans nearly 160 practices across 17 states. Compared with leading patient-engagement vendors, Parakeet rebooks no-show patients at up to 4.9x higher rates and canceled appointments at up to 4.2x higher rates. Annual recurring revenue grew 10x over the past year.

What This Round Signals

What It Means for the Agent Ecosystem

Healthcare is widely seen as the industry with the least tolerance for AI mistakes, but Parakeet didn't start there — it started with whether a patient actually gets a slot on the calendar, a rule-bound administrative process whose outcome is directly measurable in revenue. That's a pattern repeating across enterprise agent adoption: win the segment with clear audit criteria and high repetition first, prove it with verifiable financial results, then expand into harder territory. Parakeet's own roadmap follows that logic, pushing next into primary care, behavioral health, women's health, eye care, physical therapy, gastroenterology, and radiology.

What Investors Are Betting On

Canvas Ventures' logic is spelled out directly in lead partner Rebecca Lynn's public comment: she frames the future of patient engagement as one connected AI experience across every channel rather than a stack of disconnected tools, and argues Parakeet is already proving that case with measurable financial returns. The bet also rests on a more concrete lever — Parakeet runs on a results-based pricing model (appointments booked, issues resolved, revenue generated), tying its own economics directly to the metrics a healthcare buyer actually cares about, which lowers the procurement risk for a famously conservative industry.

Numbers Worth Watching

• ARR is up 10x year over year on just $13M in total funding — a capital efficiency well above most early-stage agent startups still refining their product
• No-show rebooking up to 4.9x and cancellation rebooking up to 4.2x are rare examples of healthcare-agent output translated directly into numbers a CFO can act on
• Enterprise deployment takes just 4 to 6 weeks, against a healthcare-IT-integration norm that typically runs six months or longer — a sign the product has already cleared the low-internal-IT-burden bar that usually stalls healthcare sales cycles

Watchlist Status

Parakeet Health is not currently on the watchlist. Recommend adding it under section D5 (Healthcare AI), alongside Abridge, Hippocratic AI, Suki AI, and Ambience Healthcare — tracking whether a patient-access/scheduling agent can hold this capital efficiency as it expands beyond dermatology, and whether adoption speed stays consistent across new specialties.

Today's Takeaway

Healthcare AI coverage usually asks whether an agent can handle diagnosis. Parakeet's round is a reminder that a faster path to adoption runs through something less glamorous: the patients who fall through scheduling gaps and never get rebooked — revenue every clinic is already losing but rarely treats as a technology problem. Turning that into a number a CFO can act on wins trust from a conservative buyer faster than a clinically-judging agent would.

References

• Parakeet Health Raises $10 Million Series A Following 10x Growth and Rapid Enterprise Adoption
• Parakeet Health Raises $10M in Series A Funding
• Parakeet Health raises $10M to expand AI patient engagement